Amy Wolbeck, V.P. Regulatory Affairs & Qlty at Intersect ENT, Inc. (XENT), sold 8,000 shares at $22.16 ($177K) on 2015-02-12, disclosed to the SEC on 2015-02-13.
Scheduled sale ($177k) by V.P. Regulatory Affairs & Qlty under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.05 | 2,901 | $64K | 36.1% |
| 2 | $22.16 | 5,099 | $113K | 63.9% |
| Total | $22.12 avg | 8,000 | $177K | 100% |
| Filing → |
| XENT | SELL | 2015-05-11 | $2K | — | Filing → |
| XENT | SELL | 2015-04-15 | $420K | — | Filing → |
| XENT | SELL | 2015-03-13 | $184K | — | Filing → |